Rimax Pharmaceuticals Private Limited
Pharmaceutical company specializing in drug manufacturing, distribution, and health aids.
2016 | Ghaziabad, Uttar Pradesh (India) | Active
Rimax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 246.33%
- Ebitda 315.32%
- Net Worth 36.00%
- Total Assets 35.70%
About Rimax Pharmaceuticals
Rimax Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2016 (Eight years and two months 29 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sidhartha Sinha and Sudipta Das serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909UP2016PTC088144
- Company No.
088144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Rimax Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sidhartha Sinha  | Director | 06-Dec-2016 | Current |
| Sudipta Das | Director | 06-Dec-2016 | Current |
Financial Performance of Rimax Pharmaceuticals.
Rimax Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 246.33% increase in profit. The company's net worth Soared by an impressive increase of 36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rimax Pharmaceuticals?
In 2019, Rimax Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rimax Pharmaceuticals?
Unlock and access historical data on people associated with Rimax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rimax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rimax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Rimax Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Rimax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Rimax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
- Director Appointment
Sidhartha Sekhar Sinha was appointed as a Director was appointed as a Director on 06 Dec 2016 & has been associated with this company since 8 years 2 months .
- Director Appointment
Sudipta Das was appointed as a Director was appointed as a Director on 06 Dec 2016 & has been associated with this company since 8 years 2 months .
- Company Incorporation
Rimax Pharmaceuticals Private Limited was registered on 06 Dec 2016 with Roc Kanpur & aged 8 years 2 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Rimax Pharmaceuticals Private Limited?
Rimax Pharmaceuticals Private Limited was incorporated on 06 Dec 2016.
What is authorized share capital and paid-up capital of Rimax Pharmaceuticals Private Limited?
The authorized share capital of Rimax Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Rimax Pharmaceuticals Private Limited?
Currently 2 directors are associated with Rimax Pharmaceuticals Private Limited.
- Sidhartha Sekhar Sinha
- Sudipta Das
What is the registered address of Rimax Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Rimax Pharmaceuticals Private Limited is Bs-7 Basement Ansal'S Sundaram Rdc Raj Nagar, India, Ghaziabad, Uttar Pradesh, 201001.
What is the corporate identification number (CIN) and company number of Rimax Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Rimax Pharmaceuticals Private Limited is U51909UP2016PTC088144 and the company number is 088144 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Rimax Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Rimax Pharmaceuticals Private Limited has experienced an upsurge of 36.00%.
When was the last Balance Sheet of Rimax Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Rimax Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.